Estimates of the chromium(VI) reducing capacity in human body compartments as a mechanism for attenuating its potential toxicity and carcinogenicity

Carcinogenesis

Volumn 18, Issue 3, 1997, Pages 531-537

  De Flora, Silvio ^a   Camoirano, Anna ^a   Bagnasco, Maria ^a   Bennicelli, Carlo ^a   Corbett, Gwen E ^b   Kerger, Brent D ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b CARDNO CHEMRISK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; CHROMIUM;

ARTICLE; BLOOD; BODY FLUID; CARCINOGENICITY; CONTROLLED STUDY; DETOXIFICATION; EPITHELIUM; ERYTHROCYTE; HUMAN; HUMAN TISSUE; LIVER; LUNG ALVEOLUS MACROPHAGE; LUNG PARENCHYMA; PORTAL VEIN; PRIORITY JOURNAL; REDUCTION; SALIVA; STOMACH JUICE; TOXICITY;

BIOLOGICAL AVAILABILITY; BLOOD; BODY FLUID COMPARTMENTS; CARCINOGENS, ENVIRONMENTAL; CHROMATES; CHROMIUM; FECES; FEMALE; HUMANS; LIVER; MACROPHAGES, ALVEOLAR; MALE; ORGAN SPECIFICITY; OXIDATION-REDUCTION; RESPIRATORY SYSTEM;

EID: 0031417348     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/18.3.531     Document Type: Article

References (60)

1. De Flora, S., Bagnasco, M., Serra, D. and Zanacchi, P. (1990) Genotoxicity of chromium compounds. A review. Mutat. Res., 238, 99-172.
2. De Flora, S., Camoirano, A., Bagnasco, M. and Zanacchi, P. (1995) Chromium and carcinogenesis. In Berthon, G. (ed.) Handbook on Metal Ligand Interactions in Biological Fluids. Bioinorganic Medicine, Vol. 2. New York, Marcel Dekker, pp. 1020-1036.
3. International Agency for Research on Cancer (1990) Chromium, nickel and welding. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 49. Lyon, France, IARC.
4. De Flora, S. and Wetterhahn, K.E. (1989) Mechanisms of chromium metabolism and genotoxicity. Life Chem. Rep., 7, 169-244.
5. De Flora, S. (1978) Metabolic deactivation of mutagens in the Salmonella/ microsome test. Nature (London), 271, 455-456.
6. De Flora, S., Zanacchi, P. and Bennicelli, C. (1995) Toxicity of essential and beneficial ions. Chromium. In Berthon, G. (ed.) Handbook on Metal Ligand Interactions in Biological Fluids. Bioinorganic Medicine, Vol. 2. New York, Marcel Dekker, pp. 716-725.
7. Anderson, R.A., Bryden, N.A. and Polansky, M.M. (1996) Lack of toxicity of chromium chloride and chromium picolinate (Abstract). Fund. Appl. Toxicol., 30, 294.
8. Petrilli, F.L. and De Flora, S. (1982) Interpretations on chromium mutagenicity and carcinogenicity. In Sorsa, M. and Vainio, H. (eds) Mutagens in Our Environment. New York, Alan R. Liss, Inc., pp. 453-464.
9. De Flora, S., Badolati, G.S., Serra, D., Picciotto, A., Magnolia, M.R. and Savarino, V. (1987) Circadian reduction of chromium in the gastric environment. Mutat. Res., 192, 169-174.
10. Petrilli, F.L., Rossi, G.A., Camoirano, A., Romano, M., Serra, D., Bennicelli, C., De Flora, A. and De Flora, S. (1986). Metabolic reduction of chromium by alveolar macrophages and its relationships to cigarette smoke. J. Clin. Invest., 77, 1917-1924.
11. De Flora, S., Petruzzelli, S., Camoirano, A., Bennicelli, C., Romano, M., Rindi, M., Ghelarducci, M. and Giuntini, C. (1987) Pulmonary metabolism of mutagens and its relationship with lung cancer and smoking habits. Cancer Res., 47, 4740-4745.
12. Petruzzelli, S., De Flora, S., Bagnasco, M., Hietanen, E., Camus, A.M., Saracci, R., Izzotti, A., Bartsch, H. and Giuntini, C. (1989) Carcinogen metabolism studies in human bronchial and lung parenchymal tissues. Am. Rev. Respir. Dis., 140, 417-422.
13. Maron, D. and Ames, B.N. (1983) Revised methods for the Salmonella mutagenicity test. Mutat. Res., 113, 173-215.
14. Lentner, C. Lentner, Ch. and Wink, A. (eds) (1986) Geigy Scientific Tables. Basle, Ciba-Geigy.
15. Kirsner, J.B. (1974) The stomach. In Sodeman, W.A., Jr and Sodeman, W.A. (eds) Pathologic Physiology, Mechanisms of Disease, 5th edn. Philadelphia, PA, Saunders.
16. Malagelada, J.R., Longstreth, G.F., Sumerskill, H.J. and Go, V.L.W. (1976) Measurement of gastric functions during digestion of ordinary solid meals in man. Gastroenterology, 70, 203-210.
17. Simon, G.L. and Gorbach, S.L. (1986) The human intestinal microflora. Dig. Dis., 30, 147.
18. Balboni, G.C., Bastianini, A., Brizzi, E., et al. (eds) (1982) Human Anatomy, 2nd edn. Milano, Italy, Edi-Ermes. (In Italian.)
19. Petrilli, F.L., and De Flora, S. (1978) Metabolic deactivation of hexavalent chromium mutagenicity. Mutat. Res., 54, 139-147.
20. Effros, R.M. (1991) Permeability of the blood-gas barrier. In Crystal, R.G. and West, J.B. (eds) The Lung: Scientific Foundations. New York, Raven Press, pp. 1163-1175.
21. Crapo, J.D., Barry, B.E., Gehr, P., Bachofen, M. and Weibel, E.R. (1982) Cell number and characteristics of the normal human lung. Am. Rev. Respir. Dis., 125, 332-337.
22. Green, G.M., Jakah, G.J., Low, R.B. and Davis, G.E. (1977) Defense mechanisms of the respiratory membrane. Am. Rev. Respir. Dis., 115, 479-514.
23. De Flora, S. (1984) Detoxification of genotoxic compounds as a threshold mechanism limiting their carcinogenicity. Toxicol. Pathol., 12, 337-343.
24. De Flora, S. (1985) Possible thresholds in genotoxicity and carcinogenicity resulting from detoxication mechanisms. Ann. Am. Conf. Ind. Hyg., 12, 145-155.
25. Petrilli, F.L. and De Flora, S. (1988) Metabolic reduction of chromium as a threshold mechanism limiting its in vivo activity. Sci. Total Environ., 71, 357-364.
26. Stearns, D.M., Kennedy, L.J., Courtney, K.D., Giangrande, P.H., Phieffer, L.S. and Wetterhahn, K.E. (1995) Reduction of chromium(VI) by ascorbate leads to chromium-DNA binding and, DNA strand breaks in vitro. Biochemistry, 34, 910-919.
27. Furst, A., Schlauder, M. and Sasmore, D.P. (1976) Tumorigenic activity of lead chromate. Cancer Res., 36, 1779-1783.
28. International Agency for Research on Cancer (1980) Some metals and metallic compounds. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 23. Lyon, IARC.
29. Korallus, U., Harzdorf, C. and Lewalter, J. (1984) Experimental bases of ascorbic acid therapy of poisoning by hexavalent chromium compounds. Int. Arch. Occup. Environ. Hlth, 53, 247-256.
30. Capellmann, M. and Bolt, H.M. (1992) Chromium (VI) reducing capacity of ascorbic acid and of human plasma in vitro. Arch. Toxicol., 66, 45-50.
31. Corbett, G.E., O'Flaherty, E., Kerger, B.D., Finley, B.L. and Paustenbach, D.J. (1996) Reduction kinetics of hexavalent chromium in human blood (Abstract). Fund. Appl. Toxicol., 30, 15.
32. Gray, S.J. and Sterling, K. (1950) The tagging of red cells and plasma proteins with radioactive chromium. J. Clin. Invest., 29, 1604-1613.
33. 51Cr-chromate by human erythrocytes - a role of glutathione. Acta Pharmacol. Toxicol., 50, 310-315.
34. Kitagawa, S., Seki, H., Kametani, F. and Sakurai, H. (1982) Uptake of hexavalent chromium by bovine erythrocytes and its interaction with cytoplasmic components; the role of glutathione. Chem.-Biol. Inter., 40, 265-274.
35. Wiegand, H.J., Ottenwalder, H. and Bolt, H.M. (1984) The reduction of chromium (VI) to chromium (III) by glutathione: an intracellular redox pathway in the metabolism of the carcinogen chromate. Toxicology, 33, 341-348.
36. Wiegand, H.J., Ottenwalder, H. and Bolt, H.M. (1988) Recent advances in biological monitoring of hexavalent chromium compounds. Sci. Total Environ., 71, 309-315.
37. 51Cr(VI) by human erythrocytes: evidence for a carrier-mediated transport mechanism. Sci. Total Environ., 71, 561-566.
38. Lewalter, J., Korallus, U., Harzdorf, C. and Weidemann, H. (1985) Chromium bond detection in isolated erythrocytes: a new principle of biological monitoring of exposure to hexavalent chromium. Int. Arch. Occup. Environ. Hlth, 55, 305-318.
39. Kerger, B.D., Finley, B.L., Corbett, G.E., Dodge, D.G. and Paustenbach, D.J. (1997) Ingestion of chromium (VI) in drinking water by human volunteers: absorption, distribution and excretion of single and repeated doses. J. Toxicol. Environ. Health, 50, 101-129.
40. Owens, R.A. and Hartman, P.E. (1986) Glutathione: a protective agent in Salmonella typhimurium and Escherichia coli as measured by mutagenicity and by growth delay assays. Environ. Mutag., 8, 659-673.
41. 51Cr in the albino rat. Arch. Biochem. Biophys., 79, 200-205.
42. Donaldson, R.M. and Barreras, R.F. (1966) Intestinal absorption of traces quantities of chromium. J. Lab. Clin. Med., 68, 484-493.
43. Gad, S.C., Dunn, B.J., Siino, K.M., Powers, W.J., Hoffman, G.M. and Walsh, R.D. (1986) Acute toxicity of four chromate salts. In Serrone, D.M. (ed.) Chromium Symposium 1986. An Update. Industrial Health Foundation, Pittsburgh, PA, pp. 43-58.
44. USEPA (1996) Chromium. Integrated Risk Information System (IRIS). Office of Health and Environmental Assessment, U.S. Environmental Protection Agency. Down-loaded from National Library of Medicine online service, 25 January, Washington DC.
45. Anwar, R.A., Langham, F.F. and Hoppert, C.A. (1961) Chronic toxicity studies, 3: Chronic toxicity of cadmium and chromium in dogs. Arch. Environ., 3, 456-460.
46. MacKenzie, R.D., Byerrum, R.U., Decker, C., Hoppert, C.A. and Langham, F.F. (1958) Chronic toxicity studies: Hexavalent and trivalent chromium administered in drinking water. A.M.A. Arch. Ind. Hlth, 18, 232-234.
47. Borneff, J., Engelhardt, K., Griem, W., Kunte, H. and Reichert, J. (1968) Kanzerogene Substanzen in Wasser und Boden. XXII. Mausetrankwersuch mit 3,4-Benzpyren unt Kaliumchromat. Arch. für Hygiene und Bakteriologie, 152, 45-53.
48. Mirsalis, J.C., Hamilton, C.M., O'Loughlin, K.G., Paustenbach, D.J., Kerger, B.D. and Patierno, S. (1996) Chromium (VI) at plausible drinking water concentrations is not genotoxic in the in vivo bone marrow micronucleus or liver UDS assays. Environ. Mol. Mutagenesis, 28, 60-63.
49. Zhang, J. and Li, S. (1996) Cancer mortality in a Chinese population exposed to hexavalent chromium in water. J. Occup. Environ. Med. (in press).
50. Finley, B., Kerger, B.D. and Paustenbach, D.J. (1997) Human ingestion of chromium (VI) in drinking water: pharmacokinetics following repeated exposure. Tox. Appl. Pharmacol., 142, 151-159.
51. Kerger, B.D., Paustenbach, D.J., Corbett, G.E. and Finley, B.L. (1996) Absorption and elimination of trivalent and hexavalent chromium in humans following ingestion of a bolus dose in drinking water. Toxicol. Appl. Pharmacol., 141, 145-158.
52. Kuykendall, J.R., Kerger, B.D., Jarvi, E.J., Corbett, G.E. and Paustenbach, D.J. (1996) Measurement of DNA-protein cross-links in human leukocytes following acute ingestion of chromium in drinking water. Carcinogenesis, 17, 1971-1977.
53. Paustenbach, D.J., Hays, S., Brien, B., Dodge, D.G. and Kerger, B.D. (1996) Observation of steady-state in blood and urine following human ingestion of hexavalent chromium in drinking water. J. Toxicol. Environ. Health, 49, 453-461.
54. Jones, R. (1990) Hexavalent chrome: threshold concept for carcinogenicity. Biomed. Environ. Sciences, 3, 20-34.
55. Davis, W.B. and Pacht, E.R. (1991). Extracellular antioxidant defenses. In Crystal, R.G. and West, J.B. (eds) The Lung: Scientific Foundations. New York, Raven Press, pp. 1821-1827.
56. Suzuki, Y. and Fukuda, K. (1990) Reduction of hexavalent chromium by ascorbic acid and glutathione with special reference to the rat lung. Arch. Toxicol., 64, 169-176.
57. Cantin, A.M., North, S.L., Hubbard, R.C. and Crystal, R.G. (1987) Normal alveolar epithelial lining fluids contains high levels of glutathione. J. Appl. Phvsiol. 63, 152-157.
58. De Flora, S., Romano, M., Basso, C., Bagnasco, M., Cesarone, C.F., Rossi, G.A. and Morelli, A. (1986) Detoxifying activities in alveolar macrophages of rats treated with acetylcysteine, diethyl maleate and/or Aroclor. Anticancer Res., 6, 1009-1012.
59. Stowers, S.J. and Anderson, M.W. (1985) Formation and persistence of benzo[a]pyrene metabolite-DNA adducts. Environ. Hlth Perspect., 62, 31-39.
60. Petrilli, F.L., Camoirano, A., Bennicelli, C., Zanacchi, P., Astengo, M. and De Flora, S. (1982) Specificity and inducibility of the metabolic reduction of chromium (VI) mutagenicity by subcellular fractions of rat tissues. Cancer Res., 45, 3179-3187.